Logo

Epoch Licenses Eclipse Dark Quencher Technology to Applied Biosystems for Environmental Testing

Sep 17, 2003

NEW YORK, Sept. 17 (GenomeWeb News) - Epoch Biosciences of Bothell, Wash., today announced that it has licensed its Eclipse-brand dark quencher technology to Applied Biosystems.

 

Epoch will supply ABI its technology for integration into ABI's TaqMan probes for use in 5' nuclease assays. The license agreement covers ABI's use of the quencher technology for detection of microorganisms in the environment, Epoch said.

 

Epoch will receive license fees and royalties on sales of TaqMan probes containing its technology.

 

The Eclipse dark quencher technology helps improve signals in DNA probes by suppressing signals generated by fluorescent dyes.

 

Epoch has licensed the technology to ABI for use in other TaqMan products, as well as to Amersham Biosciences, Qiagen, Takara, Glen Research, and Third Wave Technologies.

 

Breaking News
The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.